2015
Multicontrast High-Resolution Vessel Wall Magnetic Resonance Imaging and Its Value in Differentiating Intracranial Vasculopathic Processes
Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, Tirschwell DT, Hatsukami T, Anzai Y, Yuan C. Multicontrast High-Resolution Vessel Wall Magnetic Resonance Imaging and Its Value in Differentiating Intracranial Vasculopathic Processes. Stroke 2015, 46: 1567-1573. PMID: 25953365, DOI: 10.1161/strokeaha.115.009037.Peer-Reviewed Original ResearchConceptsReversible cerebral vasoconstriction syndromeVessel wall magnetic resonance imagingCerebral vasoconstriction syndromeMagnetic resonance imagingT2 hyperintensityIntracranial vasculopathyResonance imagingWall thickeningPattern of enhancementCases of atherosclerosisIntracranial vascular diseaseT2 signal characteristicsExcellent inter-reader agreementInter-reader agreementVasculitic lesionsInvasive workupWall involvementStenotic lesionsVasculopathic processPostcontrast enhancementVascular diseaseDifferential diagnosisVasculopathyLesion typeSyndrome
2011
The Secret “Spice”: An Undetectable Toxic Cause of Seizure
de Havenon A, Chin B, Thomas KC, Afra P. The Secret “Spice”: An Undetectable Toxic Cause of Seizure. The Neurohospitalist 2011, 1: 182-186. PMID: 23983854, PMCID: PMC3726077, DOI: 10.1177/1941874411417977.Peer-Reviewed Original ResearchFirst generalized seizureEmergency department physiciansGeneralized seizuresDepartment physiciansSide effectsSynthetic cannabinoidsEmergency department visitsTonic-clonic seizuresCannabinoid receptors CB1US Drug Enforcement AdministrationToxic side effectsProconvulsant effectsProvoked seizuresDepartment visitsAntiepileptic drugsToxic causesUnnecessary treatmentDifferential diagnosisPrior historyDrug toxicityReceptors CB1Detailed historyNeurological diseasesSeizuresSynthetic cannabinoid products